2BBBullish & Bearish
Hims & Hers Health, Inc. Class A Common Stock (HIMS) trades on NYSE. It operates in the Health Care sector, Drug Manufacturers - Specialty & Generic industry. Its current 2BB score is 61 out of 100.
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.
Hims & Hers Health, Inc. Class A Common Stock’s current 2BB score is 61 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 75 | High |
| Momentum | 51 | Stable |
| Financial strength | 41 | Normal |
| Quality | 97 | Very Strong |
| Risk | 44 | Moderate |
| Headquarters | San Francisco, California, United States |
| Founded | Nov 2017 |
| Employees | 2.44K |
| 52-week range | $13.74 – $65.30 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-22 | — | 0.128 | — | $972.51M |
| 2026-11-02 | — | 0.0649 | — | $910.75M |
| 2026-08-10 | -0.1 | -0.0143 | $753.21M | $713.89M |
| 2026-05-11 | -0.19 | 0.0442 | $608.10M | $629.19M |